Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Smal
资讯
2024-06-18
SHANGHAI, June 18, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the...